China Pharma Holdings, Inc. (CPHI) reported a fiscal 2021 net loss of $3.4 million, compared to a loss of $2.9 million, prior year. Loss per share was $0.07, flat with prior year.
Revenue was $9.6 million, compared to $10.9 million, last year. The company said this was mainly due to the increase of existing product sales revenue in 2021 did not exceed the one-time foreign trade orders recognized in 2020, which was approximately $1.7 million.
As of December 31, 2021, the company had cash and cash equivalents of $4.9 million.
For comments and feedback: editorial@rttnews.com